American Clinical Research Services Acquires Clinical Site Services and Patient Advertising Guru
American Clinical Research Services (“ACRS”) has announced the acquisition of Clinical Site Services (“CSSi”) and Patient Advertising Guru (“PAG”). The acquisition of the two previously merged companies demonstrates ACRS’s focus on inclusive patient centric solutions for clinical development. Both Chris Trizna (CSSi) and Evan Brett (PAG) remain as co-Presidents, joining the ACRS leadership team.
Clinical Site Services is a provider of customized, full-service site centric patient recruitment solutions. CSSi’s Local Enrollment Specialists are former study coordinators, located across the globe, that support sites to generate referrals from within the site, their community, advocacy groups, and local medical practitioners.
Patient Advertising Guru is a niche provider of advertising, providing creative development, media buying, and referral tracking services. PAG is also the creator of Research Study Rockstar, a social media resource for patient recruitment.
Both CCSi and PAG have experience servicing a range of therapeutic areas, including oncology, CNS, metabolic, and women’s health, across 50+ countries.
Reference
Latticework Capital Management’s American Clinical Research Services Acquires Clinical Site Services and Patient Advertising Guru. (2023, May 9). Business Wire.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
